Anti-dementia protective drugs such as the cholinesterase inhibitors tacrine, donezepil, and selegiline, as well as selective monoamine oxidase B inhibitors, are widely used for the treatment of Parkinson’s disease, mainly relying on their ability to interact with the GAPDH apoptotic cascade [42]. The gene discussed is GAPDH; the disease is dementia.